TY - JOUR T1 - Clinical impact of bisphosphonates in root canal therapy JF - Saudi Medical Journal JO - Saudi Med J SP - 232 LP - 238 DO - 10.15537/smj.2018.3.20923 VL - 39 IS - 3 AU - Mothanna K. AlRahabi AU - Hani M. Ghabbani Y1 - 2018/03/01 UR - http://smj.org.sa/content/39/3/232.abstract N2 - Bisphosphonates are stable structural analogs of pyrophosphate, which suppress the activity of osteoclasts, leading to decreased bone resorption. They are essential medications in the treatment of osteoporosis. Osteonecrosis of the jaw is a serious adverse effect of bisphosphonate therapy. The prevalence of bisphosphonate-related osteonecrosis of the jaw varies from 0% to 28%, and it can be triggered by dental extraction and trauma. Root canal therapy can delay, or even eliminate, the need for tooth extraction, and therefore, may reduce the risk of bisphosphonate-related osteonecrosis of the jaw. We suggest that this might be the best treatment for teeth with pulpal and/or periapical disease. ER -